CRYOPORT, INC. Accumulated Other Comprehensive Income
CRYOPORT, INC. (CYRX) had Accumulated Other Comprehensive Income of -$2.45 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.45M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.21M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.48M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$4.07M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$2.45M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$3.21M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$3.48M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$4.07M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$5.40M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$15.74M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$20.93M 10-K · filed 2026-03-05 | |
| 2024-09-30 | -$16.38M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$29.19M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$30.08M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$26.07M 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$34.10M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$34.49M 10-Q · filed 2023-08-09 | |
| 2022-12-31 | -$34.55M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $173.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.10M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $880.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $5.38M 10-Q · filed 2021-11-04 | |
| 2020-09-30 | $206.63K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $260.20K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $423.21K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$45.00K 10-K · filed 2021-03-01 | -$45.05K 10-K · filed 2020-03-10 |
| 2019-09-30 | -$66.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $38.30K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $20.85K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.15K 10-K · filed 2020-03-10 | |
| 2018-09-30 | -$43.42K 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |